Latest BioPharma News and In-Depth Analysis | BioPharma BoardRoom

26 August, 2025 | Tuesday

Helsinn and Immedica enter exclusive partnership for commercialisation of cancer supportive care products in core European markets

Helsinn Group (“Helsinn”), a fully integrated global biopharma company with a track record of over forty years of commercial execution and a st...

January 24, 2023 | Tuesday | News

Zeon Corporation Acquires Edge Precision Manufacturing Inc ("Edge"), a leading manufacturer of micro featured thermoplastic devices for diagnostic, clinical, optics, and research applications

Zeon Corporation (Zeon; head office: Chiyoda-ku, Tokyo; President and CEO: Kimiaki Tanaka), through its subsidiary Zeon Specialty Materials Inc. (Californi...

January 10, 2023 | Tuesday | News

Helix and QIAGEN Form Exclusive Global Partnership to Develop and Commercialize Companion Diagnostics for Hereditary Diseases

Partnership to leverage the Helix® Laboratory Platform and QIAGEN's biopharma relationships, NGS capabilities, and global regulatory expertise Ad...

January 06, 2023 | Friday | News

28
29
30
31
32
33
34
35
36
37

Partner Content

BioPharma BreakThrough's

Editor Picks

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

Gene Editing Breakthroughs

Innovative Drug Discovery

Vaccine Development

Biologics and Therapeutic Antibodies

× Please select an option to participate in the poll.

View poll results More polls

× You have successfully cast your vote.

{{ optionDetail.option }} {{ optionDetail.percentage }}%

More polls

About Us Media Pack Contact Us Privacy Policy

© 2025 Biopharma Boardroom. All Rights Reserved.